Tenofovir Alafenamide Fumarate/Elvitegravir
富马酸磷丙替诺福韦/埃替格韦
Report date: 2025/07/30 14:54:01
Base Information
Drug NameTenofovir Alafenamide Fumarate/Elvitegravir
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsYes Tenofovir Alafenamide FumarateElvitegravir
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesContraceptive Research And Development Organization
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A